Diabetic Peripheral Neuropathic Pain clinical trials

Explore recruiting diabetic peripheral neuropathic pain clinical trials.

Recruiting diabetic peripheral neuropathic pain studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diabetic Peripheral Neuropathic Pain trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicenter randomized, double-blind, placebo-controlled Phase 2 study to evaluate efficacy, safety, tolerability, pharmacokinetics and target engagement of GSK3858279 in adult participants with chronic Diabetic Peripheral Neuropathic Pain (DPNP) / NEPTUNE-17.

Spain, Germany, France, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Randomized, Double-blind, Active-controlled, Dose-ranging, Parallel-design Study of the Efficacy and Safety of Oral VX-993 in Subjects With Painful Diabetic Peripheral Neuropathy

France, Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

J2P-MC-LXBD: A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Poland, Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

A Double-blind, Randomized, Placebo-controlled, 4-arm Parallel-group, Multiple-Dose Study to Assess Efficacy and Safety of Medical Cannabis Aerosol via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain

Poland, Czechia, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Perineural injections of incobotulinumtoxin-A for diabetic neuropathic pain of the lower extremities: A double-blind, randomized, placebo-controlled study (PINBOT)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase I, randomized, double-blind, placebo-controlled, four-way cross-over study to evaluate the analgesic effects of TRV045 in healthy adults

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Diabetic Peripheral Neuropathic Pain trials by city

Diabetic Peripheral Neuropathic Pain in Toronto Diabetic Peripheral Neuropathic Pain in Vancouver Diabetic Peripheral Neuropathic Pain in Montreal Diabetic Peripheral Neuropathic Pain in Calgary Diabetic Peripheral Neuropathic Pain in Edmonton Diabetic Peripheral Neuropathic Pain in Ottawa Diabetic Peripheral Neuropathic Pain in Winnipeg Diabetic Peripheral Neuropathic Pain in Quebec City Diabetic Peripheral Neuropathic Pain in Hamilton Diabetic Peripheral Neuropathic Pain in Kitchener Diabetic Peripheral Neuropathic Pain in London Diabetic Peripheral Neuropathic Pain in Halifax Diabetic Peripheral Neuropathic Pain in New York Diabetic Peripheral Neuropathic Pain in Los Angeles Diabetic Peripheral Neuropathic Pain in Chicago Diabetic Peripheral Neuropathic Pain in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease